Philippine National Bank:企業の戦略・SWOT・財務情報

◆英語タイトル:Philippine National Bank - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11850
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィリピン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Philippine National Bank – Strategy, SWOT and Corporate Finance Report
Summary

Philippine National Bank – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Philippine National Bank (PNB), a subsidiary of LT Group, Inc., offers a range of banking and related financial solutions. It includes deposits, loans, insurance, foreign exchange dealing, mortgage lending, bills discounting, investment banking, fund transfers/remittance servicing, retail banking, and trust services, and online and mobile banking services. It caters to individual depositors, small and medium enterprise, domestic and international corporations, government institutions, and overseas Filipinos. The bank has presence in the Philippines, the US, Canada, Europe, the Middle East, and Asia. PNB is headquartered in Pasay City, the Philippines.

Scope

- Detailed information on Philippine National Bank required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Philippine National Bank in the form of a SWOT analysis
- An in-depth view of the business model of Philippine National Bank including a breakdown and examination of key business segments
- Intelligence on Philippine National Bank’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Philippine National Bank, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Philippine National Bank and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Philippine National Bank as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Philippine National Bank’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Philippine National Bank: Company Overview 9
Philippine National Bank: Overview and Key Facts 9
Philippine National Bank: Overview 9
Philippine National Bank: Key Facts 9
Philippine National Bank: Key Employees 11
Philippine National Bank: Key Employee Biographies 13
Philippine National Bank: Major Products and Services 14
Philippine National Bank: Company History 15
Philippine National Bank: Management Statement 19
Philippine National Bank: Locations and Subsidiaries 24
Philippine National Bank: Key Competitors 26
Philippine National Bank: Company Analysis 27
Philippine National Bank: Business Description 27
Philippine National Bank: SWOT Analysis 28
Philippine National Bank: SWOT Overview 28
Philippine National Bank: Strengths 28
Philippine National Bank: Weaknesses 29
Philippine National Bank: Opportunities 29
Philippine National Bank: Threats 30
Philippine National Bank: Corporate Financial Deals Activity 32
Philippine National Bank: Financial Deals Overview 32
Philippine National Bank: Targets and Partners 34
Philippine National Bank: Top Deals 2014 – 2018YTD* 35
Philippine National Bank: Advisors 36
Philippine National Bank: Top Financial Advisors 36
Philippine National Bank: Mergers and Acquisitions 37
Philippine National Bank: Capital Raising 38
Philippine National Bank: Divestments 39
Philippine National Bank: Recent Developments 40
Philippine National Bank: News and Events Summary 40
Philippine National Bank: Business Expansion 41
Philippine National Bank: Contracts 42
Philippine National Bank: Corporate Governance 43
Philippine National Bank: Financial Deals 44
Philippine National Bank: Financial Performance 44
Philippine National Bank: Regulatory and Legal Events 45
Philippine National Bank: Strategy and Operations 45
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: Philippine National Bank: Key Facts
Table 2: Philippine National Bank: Key Employees
Table 3: Philippine National Bank: Company History
Table 4: Philippine National Bank: Locations and Subsidiaries
Table 5: Philippine National Bank: Key Competitors
Table 6: Philippine National Bank: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Philippine National Bank: M&A Activity by Geography (TTM*)
Table 8: Philippine National Bank: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Philippine National Bank: Targets and Partners
Table 10: Philippine National Bank: Top Deals 2014 - 2018YTD*
Table 11: Philippine National Bank: Financial Advisor Ranking by Value (US$m)
Table 12: Philippine National Bank: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Philippine National Bank: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Philippine National Bank: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Philippine National Bank: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Philippine National Bank: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Philippine National Bank: Divestments by Geography (2014 - YTD*2018)
Table 18: Philippine National Bank: News and Events Summary
Table 19: Philippine National Bank: Business Expansion
Table 20: Philippine National Bank: Contracts
Table 21: Philippine National Bank: Corporate Governance
Table 22: Philippine National Bank: Financial Deals
Table 23: Philippine National Bank: Financial Performance
Table 24: Philippine National Bank: Regulatory and Legal Events
Table 25: Philippine National Bank: Strategy and Operations

List of Figures
Figure 1: Philippine National Bank: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Philippine National Bank: M&A Activity by Geography (TTM*)
Figure 3: Philippine National Bank: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Philippine National Bank: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Philippine National Bank: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Philippine National Bank: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Philippine National Bank: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Philippine National Bank: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 9: Philippine National Bank: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Philippine National Bank:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kazakhtelecom (KZTK):企業の財務・戦略的SWOT分析
    Kazakhtelecom (KZTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Putnam Investments LLC:企業の戦略的SWOT分析
    Putnam Investments LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Biocept Inc (BIOC):医療機器:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Synmosa Biopharma Corp (4114):製薬・医療:M&Aディール及び事業提携情報
    Summary Synmosa Biopharma Corp (Synmosa) is a pharmaceutical company that manufactures, markets and distributes generic medicines. The company produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It offers p …
  • Imdex Ltd (IMD):石油・ガス:M&Aディール及び事業提携情報
    Summary Imdex Limited (Imdex) is a provider of integrated technological solutions to the mineral industry. The company offers drilling fluids, drilling equipment, advanced downhole instrumentation, data management solution and analytical software for geological modeling through its AMC and REFLEX br …
  • National Australia Bank Group Ltd:戦略・SWOT・企業財務分析
    National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Holder Construction Co:企業の戦略的SWOT分析
    Holder Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Abivax SA (ABVX):企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • Origin Energy Ltd (ORG):電力:M&Aディール及び事業提携情報
    Summary Origin Energy Ltd (Origin Energy) is an integrated energy company. It generates, supplies and distributes electricity; explores and develops natural gas reserves; and produces and sells gas. The company generates electricity from natural-gas fired, coal-fired, wind, solar, pumped water stora …
  • STADA Arzneimittel AG:企業の戦略・SWOT・財務情報
    STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report Summary STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • New Age Metals Inc:企業の戦略・SWOT・財務情報
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nativis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. The company provides portfolio of pipeline candidates which are under development for various therapeutic areas such as recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma, among oth …
  • Kymab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Kymab Ltd (Kymab) is a therapeutic antibody company that provides drug and vaccine development solutions. The company offers pipepline of assets in the therapeutic areas of immuno-oncology, inflammatory disease, haematology, and infectious diseases. Its pipeline products includes KY1003-Anti …
  • BT Group plc:企業の戦略・SWOT・財務情報
    BT Group plc - Strategy, SWOT and Corporate Finance Report Summary BT Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Accu-Break Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Valeo S.A.:企業の戦略・SWOT・財務情報
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nippon Paint Holdings Co Ltd (4612):企業の財務・戦略的SWOT分析
    Nippon Paint Holdings Co Ltd (4612) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析
    Summary Mangalam Drugs and Organics Ltd (MDOL) is a chemical manufacturing company that manufactures, develops, and supplies specialty chemicals, intermediates, and active pharmaceutical ingredients. The company's active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, chloro …
  • Samsung Electronics Co Ltd (005930):電力:M&Aディール及び事業提携情報
    Summary Samsung Electronics Co Ltd (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, printer, …
  • CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆